Virbac: Availability_Half-yearly financial report_June 2018_Erratum

07:32 EDT 21 Sep 2018 | GlobalNewsWire (2014)

Virbac: Availability of the half-yearly financial report as of June 30, 2018 _ Erratum

Public release - September 21, 2018

The sales breakdown table on page 3 of the half-year financial report published on September 17, 2018 included distribution errors by geographical area.

The corrected table and related comments corrections have been restated in the semi-annual financial report available on the company's website: under the section Investors - Financial reports - 2018.

The company also amended the same corrections on the investors' presentation available on the site.

Virbac: NYSE Euronext - compartment B - ISIN code: FR0000031577/SYMBOL: VIRP
Corporate finance: +33 4 92 08 71 32 - -

Virbac: Availability_Half-yearly financial report_June 2018_Erratum

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Virbac via Globenewswire


More From BioPortfolio on "Virbac: Availability_Half-yearly financial report_June 2018_Erratum"

Quick Search


Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...